between the various antigenic systems occur, indicating that different restriction sites on the H-2 K b molecule are used for different antigens. Besides CTL restriction specificities, the mutations also affect the capacity to respond. B6 and H-2 K b mutants vary in their ability to generate H-2-restricted CTL responses against SV 40, Sendal virus (12, 13) H-4 and H-3 minor histocompatibility antigens (16) and VSV (Forman, personal communication) . In all three systems, the bml mutant shows Ir defects and does not mount an H-2K-restricted CTL response. The mechanism of this type of Ir-gene-controlled nonresponsiveness is not known.
Similar to the situation with the H-2 K b mutants, evidence was presented that two H-2 D b mutations, bml 3 and bml4, strongly influenced the H-2 Db-restricted CTL responses against the hapten AED and against Moioney leukemia virus (15, 17) . We now report the effect of these mutations on the H-2 D-restricted CTL response against H-Y.
The results indicate unequivocally for the first time with H-2 mutants that class I and class II MHC-determined CTL response defects complement each other in an F1 hybrid animal. Moreover, in this model evidence is presented that Ir genes may act at the level of both the T cell repertoire and antigen presentation.
Materials and Methods
Animals. All mice were bred at the Central Laboratory of the Netherlands Red Cross bml3 bml4
Blood Transfusion Service. The mutant strains B6.C-H-2 (bml3) and B6.C-H-2 (bml4) (18) were raised from breeding stocks supplied by Dr. R. W. Melvold and Dr. D. W. Bailey (The Jackson Laboratory, Bar Harbor, ME), respectively.
Immunization. Unless otherwise mentioned, female mice were primed by one intraperitoneal (i.p.) injection of 1.5 x 107 male spleen cells in 0.5 mi phosphate-buffered saline (PBS).
Neonatal Tolerance Induction. Female bm 14 or B6 mice were injected intraperitoneally within 24 h after birth with a mixture of 5 x 107 spleen and bone marrow cells from female (B6 x bml4)F~ animals in a volume of 0.1 ml. Tolerance was tested by skin grafting.
In Vitro Generation of H-Y-Specific CTL. CTL were generated as previously described (3) . Spleen cells (108) from in vivo-primed female mice were stimulated with 2,500 radirradiated male spleen cells (108) in 80-ml culture medium for 5 d at 37°C in humidified air with 5% CO~. The culture medium consisted of Iscove's modified Dulbecco's medium (IMDM; Gibco Laboratories, Grand Island, NY) supplemented with 10% pooled human serum, penicillin (100 IU/ml), streptomycin (100 #g/ml), and 2-mercaptoethanol (2 x 10 -5 M).
Cell-mediated Lymphocytotoxicity. The standard error of triplicate cultures was always less than 3% specific 5aCr release.
Results
bml3 and bml4 Mice Are Low Responders in the CTL Response to H-Y. H-Yprimed bml 3 and bml4 spleen cells restimulated in vitro with male syngeneic spleen cells did not generate H-Y-specific CTL (Table I) . However, in a small number of experiments ('~1 out of 10) we observed weak H-Y-specific CTL responses in these mutants, indicating that bml3 and bml4 are not complete CTL nonresponders to H-Y (data not shown). Different immunization procedures (s.c.; i.v.; footpad immunization) or the addition of IL-2 to the culture medium during in vitro restimulation did not elevate the low CTL responsiveness of bm 13 and bm 14 to H-Y (data not shown). In contrast, H-Y-primed B6 spleen cells showed strong H-Y-specific CTL responses restricted by H-2 D b (Table I) . Furthermore, B6 anti-H-Y CTL were not able to lyse male bml 3 or male bml4 target cells (Table I ). This indicates that the mutations in bm 13 and bml 4 have altered extensively the B6 H-Y-specific restriction specificities. Allogeneic CTL specific for the mutated H-2 D b molecule could efficiently lyse bm 13 and bm 14 target cells, indicating that defective expression of the H-2 D molecule on the target cells cannot explain the above findings (Table II) .
Fine Spec~city of Alloimmune CTL Directed Against H-2 D. Effector cells were generated in all possible combinations between B6, bm 13, and bm 14 and tested against B6, bm 13, and bml 4 target cells. The results in Table II indicate that bml3 is closer to B6 than is bml4 with respect to CTL allospecificities. B6 responder cells generated a weak CTL response against bml3 alloantigen, in contrast to the strong response observed against bm 14. Furthermore, bm 14 anti-bml3 CTL lysed B6 target cells to the same extent as bml3 targets, whereas bm 13 anti-bm 14 CTL showed a much lower level of cross-reactivity against B6 targets. Another interesting observation is the asymmetry in CTL responses. In contrast to the weak B6 anti-bm 13 CTL response, bm 13 responder cells generate strong alloreactivity against B6. bml3 anti-B6 CTL and bml4 anti-B6 CTL crosskill, to some extent, bml4 and bml 3 targets, respectively. However, in the reverse direction, B6 anti-bml 3 and B6 anti-bml4 CTL do not show any crossreactivity. Finally, it can be concluded from Table II that both bml 3 and bml4 (although the latter to a lesser extent) share determinants with B6, as defined by allogeneic CTL. * 5 x 107 responder cells were cultured with 5 × 107 stimulator cells (2,500 tad irr.) in 80 ml culture medium during 5 d at 37 °C, after which 51 period the effector cells were tested on Cr-labeled target cells. * LPS blasts. e Mean percentage specific 5~Cr-release of three experiments; effector to target cell ratio 16:1. (Table IIIA) . After sensitization of Fl females with male B6 spleen cell, identical results were obtained (Table  IIIA) . However, sensitization of (B6 × bml 3)F1 females with male bml 3 spleen cells or sensitization of (B6 × bml4)F1 females with male bml4 spleen cells did not result in the generation of H-Y-specific CTL (Table IIIA) . Finally, (B6 × bml3)F~ females were primed in vivo by either Fl or B6 male spleen cells and restimulated in vitro with male bml 3 spleen cells and vice versa. Also under these conditions we could not measure any H-Y-specific CTL activity (Table III   B ).
(B6 × bml3)Fl and (B6 × bml4)F1 Hybrids Respond to HoY Afier Sensitization with

Genetic Complementation Between bml2, bml3, and bml4 for H-Y-Specific CTL
Responses. The I-A b mutant bm 12 is a nonresponder in CTL reactivity and T cell proliferation to H-Y (3, 19) . Therefore, it was of interest to see whether bml2 could complement bml3 or bml4 in an Fl hybrid for the H-Y-specific CTL response. From Table IV , it is clear that (bml2 x bml3)F~ and (bml2 x bm 14)F1 hybrids can respond against H-Y, indicating transcomplementation between a class-II molecule (I-A b) involved in the antigen-specific recognition by T helper cells and a class I molecule (H-2 D u) involved in the antigen-specific recognition by CTL precursors. As expected, bml 3 and bml4 could not complement each other for the generation of H-Y-specific CTL (Table IV) .
Failure of B6 or D b Mutant Mice Tolerant of Each Other to Respond to Tolerogenic Allogeneic Male Cells. The mechanism underlying the inability of bml4 to generate anti-H-Y CTL was further investigated by injecting female bml4 mice within 24 h after birth with a mixture of spleen and bone-marrow cells of (B6 X bml4)Fl female mice. These neonatally injected bml4 mice were tested after 8 * Responder female mice were primed in vivo and their spleen cells restimulated in vitro with the indicated male spleen cells. * LPS blasts; H-2 K and -D alleles in parentheses. 0 F~ hybrid target cells syngeneic with the responder haplotype were used. t 4R --B10.A(4R); 5R = B10.A(5R).
Percentage specific ~'Cr-release; effector to target cell ratio 16:1. NT, not tested. male (B6 x bml4)F~ spleen cells, but failed to respond after sensitization with male bm14 spleen cells. Thus, H-Y-specific CTL responses were only observed in neonatally tolerized animals when responder type T cells and responder type antigen-presenting cells (apc) were used (Table V) .
Discussion
Our findings clearly demonstrate that the CTL response to H-Y is regulated by H-2 D gene products. Structural alterations of the H-2 O b molecule in the bm 13 and bm 14 mutant strains lead to changes in restriction speciflcities and in responsiveness. This is further support for the notion that class-I determinants, recognized by H-2 K/D-restricted CTL, act as Ir-gene products (1-7, 13, 16, 17) . Changes in restriction specificities in bml3 and bml4 compared with B6 have been observed in three other systems: (a) H-2 Db-restricted Moloney virusspecific CTL do not iyse virus~infected bm13 or bm14 target cells (17); (b) H-2 Db-restricted CTL specific for the hapten AED are unable to kill hapten-modified bm 13 and bm 14 targets (15) , and (c) Melvold et al. (20) reported that the biologic activity of a mutant non-H-2 histocompatibility antigen was dependent on the simultaneous presence of both the mutant minor H antigen and H-2 D b. The bm13 mutant could replace H-2 D b in this latter interaction, but bm14 could not. This corresponds with our data that bm 13 is closer to B6 than bm14 with respect to allogeneic CTL determinants (Table II) . The results in Table II also show that bml 3 and bm14 still share CTL allodeterminants with B6, which is apparently not reflected in the presence of shared restriction specificities for H-2 Db-restricted CTL responses to H-Y, Moloney virus, or AED. It can be envisaged, however, that different antigens (like the minor histocompatibility antigen reported above) use different restriction sites on the H-2 D b molecule. Apart from restriction specificities, the bm 13 and bml4 mutations also affect the magnitude of CTL responses: both mutants are CTL nonresponders to H-Y (this paper) and bm14 does not mount a CTL response to Moloney virus (17) . However, bm 13 does respond to Moloney virus, although the restriction preference is shifted to H-2 K b (17) . Thus, although a close relationship exists between CTL-restriction specificities, CTL regulating determinants and CTLallospecificities, in some instances CTL regulating determinants on one class I molecule influence the CTL response restricted by another class I molecule (17, 21) .
Our findings are somewhat in contrast with data of Simpson et al. (22) who showed that bm 14 can generate H-Y-specific CTL, whereas we observed weak H-Y-specific CTL responses only in a minority of experiments.
From our analysis of the CTL nonresponsiveness to H-Y of the bml2 I-A mutant, we concluded that T helper cells recognize the H-Y antigen in the context of the I-Abal3 (class-II) molecule on adherent cells, whereas CTL precursors recognize the antigen in the context of the D b (class-I) molecule on adherent as well as nonadherent cells. With spleen cells from primed animals, the requirement for T helper cells could be bypassed with interleukin-2 (3). The current finding that the bml2 class-II mutant on the one hand and the bml3 and bml4 class-I mutants on the other complement each other for the H-Y-specific CTL response, further supports the idea that two separate Ir gene-controlled pathways are needed for this response (2) . Moreover, the complementation data show that the need for tolerance of the mutant class-II and class-I molecules in the (bm 12 × bml3)F~ and (bml2 × bml4)Fx hybrids does not create deletions in the I-A brestricted T helper cell and Db-restricted CTL repertoire for H-Y. The same holds for the Db-restricted CTL repertoire for H-Y in the (B6 × bml 3)F~ and (B6 × bml4)Fl hybrids.
The two main observations pertinent to the mechanism of H-2 D-controlled nonresponsiveness are the following: 1) (responder × nonresponder)Fl cells react against antigen presented on F~ or responder parental cells but do not respond to antigen presented on nonresponder parental cells; 2) B6 or D b mutant mice tolerant of each other fail to respond to the male antigen presented on the tolerogenic allogeneic cell. Observation 1 is the classical response pattern in Ir gene-controlled nonresponsiveness, although we recently documented an important exception to this rule in experiments on the nonresponsiveness to H-Y of the bml2 I-A mutant (3). The classical response pattern can be explained along two main lines: lack of appropriate antigen presentation, or deletion(s) in the T cell repertoire (23) (24) (25) . Observation 2) is in line with other recent experiments demonstrating holes in the allorestricted T cell repertoire. Thus, it was shown that B6 mice neonatally tolerant of H-2 k did not generate a CTL response to H-2 k plus vaccinia virus (26) , although B6 spleen cells acutely depleted of anti-H-2 k reactivity by filtration through semiallogeneic recombinant or F~ hosts did respond to H-2 k plus vaccinia virus (26) . In the proliferative T cell response against the synthetic polypeptide GLT, it was seen that elimination by BUdR and light of T cells specific for alloantigen X can create a deletion in the T cell repertoire restricted by alloantigen Y (27) .
In contrast to our experiments concerning allorestricted CTL responses in a responder/nonresponder neonatal tolerance situation, excellent allorestricted T cell populations specific for minor histocompatibility antigens and the hapten TNP were seen following neonatal tolerance induction using two responder type strains (28, 29) . H-2 Ir gene-controlled nonresponsiveness is currently attributed to the absence of functional T cells rather than inappropriate antigen presenta-tion (30) (31) (32) (33) , the evidence being mainly based on high responses of highresponder type T cells to antigen presented on low-responder type antigenpresenting cells (apc).
However, the situation may not be as simple as that, because (a) the antigen seen on apc in the context of allogeneic MHC molecules is different from that seen on syngeneic apc and may therefore be under a different Ir gene control as in fact demonstrated (30) (b). Cytochrome c-specific T cell hybridomas of B 10.A and B 10.A(5R) origin only responded to pigeon cytochrome c fragment 81-104 when this antigen was presented on high-responder B10.A apc, but not when presented on low-responder B10.A(5R) apc. This indicates that the relevant MHC molecule (Ia in this case) on the apc determined whether these hybridomas were triggered (34) . In later experiments, these results were extended to the population level (35). Therefore, in the final analysis the various interactions between antigen, MHC molecules, and T cell receptors probably determine whether a reaction is triggered. This notion does not rule out that nonresponsiveness may be the result of lack of T cells in the repertoire that are capable of being triggered by a particular antigen-MHC combination. For example, in our analysis of the CTL nonresponsiveness to H-Y of the bm 12 I-A mutant, only evidence for a deletion in the T cells was found. In the neonatal tolerance experiments with the bml3 and bm 14 nonresponders to H-Y, a response was only seen with responder type T cells and responder type apc, indicating that both the T cell source and the MHC type of the apc have to be taken into account in this experimental situation.
Summary
The cytotoxic T-lymphocyte (CTL) response against the male-specific antigen H-Y in C57BL/6 (B6, H-2 b) mice is regulated by the I-A b and D b molecules. From previous studies, we concluded that the bm 12 I-A b mutant does not respond to H-Y, because of a deletion in its T-helper-cell repertoire. We now demonstrate that two D b mutants, bml3 and bml4, also fail to generate a CTL response to H-Y. The bml2 class-II mutant on one hand and the bml3 and bml4 class-I mutants on the other complemented each other for the H-Y-specific CTL response in (bml2 x bml 3)Fl and (bml2 x bml4)F1 hybrids. This indicates that the need for tolerance of the mutant class II and class I molecules in these hybrids does not create deletions in the I-Ab-restricted T helper cell and D brestricted CTL repertoire for H-Y. This study constitutes the first demonstration with H-2 mutants that a CTL response controlled by class I and class II MHC molecules is complemented in an F1 cross between a class I and a class II nonresponder. (B6 x bml 3)Fl and (B6 X bml4)F~ hybrids only responded to H-Y when the antigen was presented on F1 or B6 antigen-presenting cells (apc) but not on D b mutant apc. B6 or D b mutant responders rendered neonatally tolerant of each other failed to respond to the H-Y antigen presented on the tolerogenic allogeneic cell. In the tolerized animals, a response was only seen with responder (B6) type T cells and responder type (B6) apc, indicating that both the T cell source and the MHC type of the apc have to be taken into account in this system. Thus, Ir genes may act at the level of both the T cell repertoire and antigen presentation.
